Stem cell-based therapy for the treatment of type 1 diabetes mellitus

Regenerative Medicine

Volumn 2, Issue 2, 2007, Pages 171-177

  Krishna, K Ananda ^a   Rao, G Venkateshwara ^a   Rao, K R S Sambasiva ^a  

^a ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

cells; Insulin secreting; Pancreas; Stem cells; Type 1 diabetes

Indexed keywords

ALGINIC ACID; AZATHIOPRINE; BARIUM; CYCLOSPORIN; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DAMAGE; CELL ENCAPSULATION; CELL REGENERATION; CHROMOSOME 10P; CHROMOSOME 11P; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 2Q; CHROMOSOME 3Q; CHROMOSOME 6P; CHROMOSOME 6Q; CONTINUOUS INFUSION; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIVER CELL; MEDICAL ETHICS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TERATOMA; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MULTIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 34249662694     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.2.171     Document Type: Review

References (62)

1. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197 (1997).
2. Elsenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314, 1360-1368 (1986).
3. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15, 516-542 (1994).
4. Eizirik DL, Mandrup-Poulsen T: A choice of death: the signal-transduction of immune-mediated β-cell apoptosis. Diabetologa 44, 2115-2133 (2001).
5. Mathis D, Vence L, Benoist C: β-cell death during progression to diabetes. Nature 414, 792-798 (2001).
6. Dupre J, Kolb H: Cyclosporin-induced remission of IDDM after early intervention - association of 1 yr of cyclosporin treatment with enhanced insulin secretion. Diabetes 37, 1574-1582 (1988).
7. Feutren G, Assan R, Karsenty G et al.: Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset - results of a multicenter double-blind trial. Lancet 2, 119-124 (1986).
8. Wood JR, Moreland EC, Voikening LK, Svoren BM, Butler DA, Laffei LM: Durability of insulin pump use in pediatric patients with Type 1 diabetes. Diabetes Care 29, 2355-2360 (2006).
9. Colino AE, Lopez CM, Alvarez GMA, Alonso BM, Martin FM, Barrio CR: Continuous subcutaneous insulin infusion in pediatric patients with Type 1 diabetes mellitus. An. Pediatr. (Barr) 64, 21-27 (2006).
10. Valensi P, Moura I, Le Magoarou M, Paries J, Perret G, Attali, JR: Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabetes Metab. 23, 51-57 (1997).
11. Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M: Long-term safety efficacy and side-effects of continuous subcutaneous insulin infusion treatment for Type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologa 32, 421-426 (1989).
12. Calabrese G, Bueti A, Santeusanio F et al.: Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. Diabetes Care 5, 457-465 (1982).
13. Harrison LC: The prospect of vaccination to prevent Type 1 diabetes. Hum. Vaccin. 1, 143-150 (2005).
14. Yang LJ: Liver stem cell-derived β-cell surrogates for treatment of Type 1 diabetes. Autoimmun. Rev. 5, 409-413 (2006).
15. Cheung AT, Dayanandan B, Lewis JT et al.: Glucose dependent insulin release from genetically engineered K cells. Science 290, 1959-1962 (2000).
16. Ber I, Shternhall K, Perl S et al.: Functional persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 278, 31950-31957 (2003).
17. Lu Y, Wang Z, Zhu M: Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann. Clin. Lab. Sci. 36, 127-136 (2006).
18. Janghorbani M, Feskanich D, Willett WC, Hu F: Prospective study of diabetes and risk of hip fracture: the nurse' health study. Diabetes Care 29, 1573-1578 (2006).
19. Kawasaki E, Awata T, Ikegami H et al.: Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and Type 1 diabetes in Asian populations. Am. J. Med. Genet. A 140, 586-593 (2006).
20. Zheng W, She JX: Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and Type 1 diabetes. Diabetes 54, 906-908 (2005).
21. Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2, 1279-1283 (1974).
22. Palmer JP, Asplin CM, Clemons P et al.: Insulin antibodies in insulin-dependent diabetic patients before insulin-treatment. Science 222, 1337-1339 (1983).
23. Kuglin B, Gries FA, Kolb H: Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 37, 130-132 (1988).
24. Baekkeskov S, Aanstoot HJ, Christgau S et al.: Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizng enzyme. glutamic acid decarboxylase. Nature 347, 151-156 (1990).
25. Baekkeskov S, Nielsen JH, Marner B. Bilde T, Ludvigsson J, Lernmark A: Autoantibodles in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298, 167-169 (1982).
26. Lan MS, Wasserfall C, Maclaren NK, Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 93, 6367-6370 (1996).
27. Christie MR, Tun RY, Lo SS et al.: Antibodies to GAD and tryptic fragments of islet 64 K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes 41, 782-787 (1992).
28. Akashi T, Nagafuchi S, Anzai K et al.: Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9, 1159-1164 (1997).
29. Kolb H, Burkart V, Appels B et al.: Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J Autoimmun. 3, 117-120 (1990).
30. Panagiotopoulos C, Qin H, Tan R, Verchere CB: Identification of a β-cell-specific HLA class I restricted epitope in Type 1 diabetes. Diabetes 52, 2647-2651 (2003).
31. Segev H, Fishman B, Ziskind A, Shulman M. Itskovitz-Eidor J: Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22, 265-274 (2004).
32. Bongso A, Fong CY, Ng SC, Ratnam S: Isolation and culture of inner cell mass cells from human blastocysts. Hum. Reprod. 9, 2110-2117 (1994).
33. Reubinoff BE, Pera W, Fong CY, Trounson A, Bongso A: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000).
34. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
35. Thomson JA, Kalishman J, Golos TG et al.: Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92, 7844-7848 (1995).
36. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T, Petersen BE: Teratoma formation leads to failure of treatment for Type I diabetes using embryonic stem cell-delved insulin-producing cells. Am. J. Pathol. 166, 1781-1791 (2005).
37. Dean SK, Yulyana Y, William G, Sidhu KS, Tuch BE: Differentiation of encapsulated embryonic stem cells after transplantation. Trasplantation 82, 1175-1184 (2006).
38. Hess D, Li L, Martin M et al.: Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21, 763-770 (2003).
39. Hori Y, Gu X, Xie X, Kim SK: Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2, E103 (2005).
40. Burns CJ, Minger SL, Hall S et al.: The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem. Biophys. Res. Commun. 326, 570-577 (2005).
41. Korbling M, Robinson S, Estrov Z, Champlin R, Shpall E: Umbilical cord blood-derived cells for tissue repair. Cytotherapy 7, 258-261 (2005).
42. Zhao Y, Wang H, Mazzone T: Identification of stem cells from human umbilical cord blood with embryonic and hematopoletic characteristics. Exp. Cell Res. 312, 2454-2464 (2006).
43. Tayaramma T, Ma B, Rhode M, Mayer H: Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells 24, 2858-2867 (2006).
44. Todorov I, Nair I, Ferreri K et al.: Multipotent progenitor cells isolated from adult human pancreatic tissue. Transplant Proc. 37, 3420-3421 (2005).
45. Tian C, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J: Prevention of Type 1 diabetes by gene therapy. J. Clin. Invest. 114, 969-978 (2004).
46. Statskas C, Chan J, Field J et al.: Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr. Gene Ther. 6, 45-58 (2006).
47. Bonner-Weir S, Taneja M. Weir GC et al.: In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA 97, 7999-8004 (2000).
48. Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M: Insulin production by human embryonic stem cells. Diabetes 50, 1691-1697 (2001).
49. Yang L, Li S, Hatch H et al.: In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc. Nalt Acad. Sci. USA 99, 8078-8083 (2002).
50. Bernard C, Berthault MF, Saulnier C, Ktorza A: Neogenesis vs. apoptosis as main components of pancreatic β cell mass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J. 13, 1195-1205 (1999).
51. Friday RP, Trucco M, Pietropaolo M: Genetics of Type 1 diabetes mellitus. Diabetes Nutr. Metab. 12, 3-26 (1999).
52. Pociot F, McDermott MF: Genetics of Type 1 diabetes mellitus. Genes Immun. 3, 235-249 (2002).
53. Hyoty H, Taylor KW: The role of viruses in human diabetes. Diabetologia 45, 1353-1361 (2002).
54. Gale EA: A missing link in the hygiene hypothesis? Diabetologia 45, 588-594 (2002).
55. Ellis TM, Atkinson MA: Early infant diets and insulin-dependent diabetes. Lancet 347, 1464-1465 (1996).
56. Dahlquist GG, Patterson C, Soltesz G: Infections and vaccinations as risk factors for childhood Type 1 (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB substudy 2 study group. Diabetologia 43, 47-53 (2000).
57. Pasquali L, Fan Y, Trucco M, Ringquist S: Rehabilitation of adaptive immunity and regeneration of β cells. Trends Biotechnol. 24, 516-522 (2006).
58. Trucco M: Is facilitating pancreatic β cell regeneration a valid option for clinical therapy? Cell Transplant. 15, S75-S84 (2006).
59. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC: Sustained β cell apoptosis in patients with long-standing Type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48, 2221-2228 (2005).
60. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC: Direct evidence of attempted β cell regeneration in an 89-year-old patient with recent-onset Type 1 diabetes. Diabetologia 49, 1838-1844 (2006).
61. Sordi V, Malosio ML, Marchesi F et al.: Human bone marrow mesenchymal stem celli transfected with human insulin genes can secrete insulin stably. Blood 106, 419-427 (2005).
62. Campbell S: Request for applications: islet cell replacement in Type 1 diabetes. Cell Biochem. Biophys. 40, 23-24 (2004).